According to Telix Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -ยฃ0.19. In 2022 the company made an earnings per share (EPS) of -ยฃ0.19 a decrease over its 2021 EPS that were of -ยฃ0.17.
Year | EPS | Change |
---|---|---|
2022 | -ยฃ0.19 | 10.63% |
2021 | -ยฃ0.17 | 53.99% |
2020 | -ยฃ0.11 | 60.51% |
2019 | -ยฃ0.06831 | 73.49% |
2018 | -ยฃ0.03938 | 24.02% |
2017 | -ยฃ0.03175 | |
2000 | -ยฃ0.006884 | 72% |
1999 | -ยฃ0.004002 |